Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research ...

Moderna will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental ...

The Coalition for Epidemic Preparedness Innovations said it will invest $54.3 million with Moderna to fund a Phase 3 trial of ...

Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research ...

The fresh capital provides another shot for Moderna's candidate against bird flu, which earlier this year lost its government ...

Moderna Inc. will get as much as $54.3 million for a late-stage trial of its bird flu vaccine in a sign of how outside groups ...

As support from the U.S. government has evaporated, Moderna is leaning on an old ally to carry plans for its prospective mRNA ...

The Coalition for Epidemic Preparedness Innovations (CEPI), a public-private partnership, is providing up to $54.3 million in ...

Funding support from outside groups could be opening a new chapter for Moderna (NASDAQ:MRNA) as the company advances its bird ...

Moderna is down 20.5% since the beginning of the year, and at $33.39 per share, it is trading 29.7% below its 52-week high of $47.53 from January 2025. Investors who bought $1,000 worth of Moderna’s ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the morning session after the company announced it would ...

Moderna Inc. will get as much as $54.3 million for a late-stage trial of its bird flu vaccine in a sign of how outside groups could help fill the void after the Trump administration slashed federal ...